Find your next paid study

University of California, San FranciscoNCT05396872

~$10 – $675

Actual pay is set by the research site.

Phase 3

A Phase 3 Open-label, Randomized, Active-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Orally Administered BAY 2927088 Compared With Standard of Care as a First-line Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With HER2-activating Mutations

Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epider…

Advanced Non-small Cell Lung Cancer, HER2 Mutation

~$50 – $2,250

Actual pay is set by the research site.

BayerNCT06452277

Suicide and DepressionAdolescent Behavior

The Center for Enhancing Triage and Utilization for Depression and Emergent Suicidality (ETUDES) in Pediatric Primary Care-iCHART RCT

This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in th…

University of PittsburghNCT05748730

Actual pay is set by the research site.

Phase 2

ParpVax2: A Phase II Study Of Maintenance Niraparib Plus Ipilimumab In Patients With Metastatic Pancreatic Cancer Whose Disease Has Not Progressed On Platinum-Based Therapy

The main goal of this study is to look at the effectiveness and anti-tumor activity (preventing growth of the tumor) of the drugs niraparib and ipilimumab, on …

Pancreatic Adenocarcinoma Metastatic

Abramson Cancer Center at Penn MedicineNCT06747845

~$75 – $2,000

Actual pay is set by the research site.

Phase 4

Osteopathic Manipulative Treatment as an Adjunct Therapy for Adhesive Capsulitis

The goal of this clinical trial is to learn if Osteopathic Manipulative Treatment (OMT) is an effective addition to treatment of adhesive capsulitis. OMT is a …

Adhesive Capsulitis of the ShoulderFrozen Shoulder

University Hospitals Cleveland Medical CenterNCT07497737

~$25 – $1,000

Actual pay is set by the research site.

Phase 1

A Phase 1, Open-label, Multicenter, Dose-escalation and Cohort Expansion Study of OKN4395, a Triple Antagonist of EP2, EP4, and DP1 Prostanoid Receptors, as Monotherapy and in Combination With Pembrolizumab, in Patients With Advanced Solid Tumors

The purpose of this study is to investigate the study drug, OKN4395, administered alone and in combination with pembrolizumab. The overall objectives of this …

Solid TumoursSarcomaHNSCC+12 more

Solid TumorSolid CarcinomaAdvanced Solid Tumor+2 more

~$150 – $4,500

Actual pay is set by the research site.

Epkin

Phase 1

FORTRAS: Phase I, Investigator Initiated, Dose-escalation Clinical Trial Evaluating a CD8 Alpha/Beta Armored RAS G12D/HLA-A*11:01-specific T-cell Receptor Therapy (MSK-TCR5) in Patients With Advanced Solid Tumors

The purpose of this study is to test the safety of MSK-TCR5 in participants with advance solid tumor cancer that has a KRAS, HRAS, or NRAS G12D mutation.

Memorial Sloan Kettering Cancer CenterNCT07638371

~$150 – $3,000

Actual pay is set by the research site.

Radiation TherapyVirtual Reality

Effectiveness of Virtual Reality in the Management of Anxiety for Patients Undergoing Radiotherapy

The purpose of this study is to evaluate the use and functionality of virtual reality (VR) during radiation therapy treatments for patients with prostate, brea…

Wake Forest University Health SciencesNCT07324577

Actual pay is set by the research site.

Overactive Bladder SyndromeOveractive BladderUrinary Frequency+1 more

A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Overactive Bladder

The purpose of this clinical trial is to compare the Emsella Chair therapy to Sham and to determine whether electromagnetic technology is effective in the trea…

Corewell Health EastNCT04873037

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells in Children and Young Adults With Recurrent, Progressive, or Refractory Brain Tumors

Each patient will receive up to 12 cycles of TGFβi NK cell infusions. Each cycle will be of 4 weeks duration. During the first 3 weeks, TGFβi NK cells will be …

High Grade Glioma

Nationwide Children's HospitalNCT04254419

~$150 – $3,000

Actual pay is set by the research site.

A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer (FAST-GO)

This study evaluates how the treatment for gastroesophageal cancer affects physical function in patients who receive chemotherapy as part of their treatment fo…

Clinical Stage I Esophageal Adenocarcinoma AJCC v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastric Cancer AJCC v8+9 more

Actual pay is set by the research site.

Cardiometabolic Risk Factors in Adult Wheelchair Users

Examining the Effects of Live Telehealth Exercise Training on Cardiometabolic Outcomes in Wheelchair Users

The study aims to test the benefits of a 24-week, cardio-emphasized Movement-to-Music exercise program for reversing cardiometabolic health risk factors compar…